Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: E9ASQ0
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 228 | 232 | PF00656 | 0.555 |
CLV_MEL_PAP_1 | 145 | 151 | PF00089 | 0.578 |
CLV_NRD_NRD_1 | 176 | 178 | PF00675 | 0.507 |
CLV_NRD_NRD_1 | 190 | 192 | PF00675 | 0.480 |
CLV_NRD_NRD_1 | 210 | 212 | PF00675 | 0.427 |
CLV_PCSK_FUR_1 | 208 | 212 | PF00082 | 0.590 |
CLV_PCSK_KEX2_1 | 176 | 178 | PF00082 | 0.503 |
CLV_PCSK_KEX2_1 | 190 | 192 | PF00082 | 0.493 |
CLV_PCSK_KEX2_1 | 208 | 210 | PF00082 | 0.438 |
CLV_PCSK_SKI1_1 | 217 | 221 | PF00082 | 0.542 |
CLV_PCSK_SKI1_1 | 230 | 234 | PF00082 | 0.477 |
CLV_PCSK_SKI1_1 | 241 | 245 | PF00082 | 0.467 |
CLV_PCSK_SKI1_1 | 78 | 82 | PF00082 | 0.243 |
DEG_Nend_Nbox_1 | 1 | 3 | PF02207 | 0.400 |
DOC_CYCLIN_yClb5_NLxxxL_5 | 13 | 21 | PF00134 | 0.449 |
DOC_MAPK_gen_1 | 13 | 21 | PF00069 | 0.307 |
DOC_MAPK_MEF2A_6 | 13 | 21 | PF00069 | 0.346 |
DOC_PP2B_LxvP_1 | 106 | 109 | PF13499 | 0.335 |
DOC_USP7_MATH_1 | 112 | 116 | PF00917 | 0.581 |
DOC_USP7_MATH_1 | 126 | 130 | PF00917 | 0.603 |
DOC_USP7_MATH_1 | 157 | 161 | PF00917 | 0.657 |
DOC_WW_Pin1_4 | 135 | 140 | PF00397 | 0.621 |
DOC_WW_Pin1_4 | 163 | 168 | PF00397 | 0.555 |
DOC_WW_Pin1_4 | 251 | 256 | PF00397 | 0.691 |
LIG_14-3-3_CanoR_1 | 114 | 124 | PF00244 | 0.680 |
LIG_14-3-3_CanoR_1 | 135 | 139 | PF00244 | 0.607 |
LIG_14-3-3_CanoR_1 | 148 | 155 | PF00244 | 0.682 |
LIG_14-3-3_CanoR_1 | 208 | 214 | PF00244 | 0.599 |
LIG_14-3-3_CanoR_1 | 73 | 78 | PF00244 | 0.423 |
LIG_Actin_WH2_2 | 57 | 75 | PF00022 | 0.349 |
LIG_APCC_ABBA_1 | 64 | 69 | PF00400 | 0.363 |
LIG_FHA_1 | 119 | 125 | PF00498 | 0.739 |
LIG_FHA_1 | 213 | 219 | PF00498 | 0.573 |
LIG_LIR_Gen_1 | 56 | 67 | PF02991 | 0.449 |
LIG_LIR_Gen_1 | 85 | 94 | PF02991 | 0.337 |
LIG_LIR_Nem_3 | 214 | 219 | PF02991 | 0.520 |
LIG_LIR_Nem_3 | 237 | 243 | PF02991 | 0.484 |
LIG_LIR_Nem_3 | 85 | 89 | PF02991 | 0.337 |
LIG_Rb_LxCxE_1 | 214 | 231 | PF01857 | 0.514 |
LIG_Rb_LxCxE_1 | 23 | 45 | PF01857 | 0.300 |
LIG_SH2_CRK | 216 | 220 | PF00017 | 0.517 |
LIG_SH2_CRK | 86 | 90 | PF00017 | 0.344 |
LIG_SH2_SRC | 67 | 70 | PF00017 | 0.344 |
LIG_SH2_STAP1 | 67 | 71 | PF00017 | 0.344 |
LIG_SH2_STAP1 | 86 | 90 | PF00017 | 0.145 |
LIG_SH2_STAT3 | 90 | 93 | PF00017 | 0.328 |
LIG_SH2_STAT5 | 90 | 93 | PF00017 | 0.344 |
LIG_SH3_2 | 109 | 114 | PF14604 | 0.621 |
LIG_SH3_3 | 105 | 111 | PF00018 | 0.145 |
LIG_SH3_3 | 88 | 94 | PF00018 | 0.349 |
LIG_TRAF2_1 | 236 | 239 | PF00917 | 0.478 |
LIG_WW_3 | 107 | 111 | PF00397 | 0.545 |
MOD_CDC14_SPxK_1 | 166 | 169 | PF00782 | 0.571 |
MOD_CDK_SPxK_1 | 163 | 169 | PF00069 | 0.595 |
MOD_CDK_SPxxK_3 | 135 | 142 | PF00069 | 0.654 |
MOD_CK1_1 | 115 | 121 | PF00069 | 0.753 |
MOD_CK1_1 | 143 | 149 | PF00069 | 0.700 |
MOD_CK1_1 | 158 | 164 | PF00069 | 0.565 |
MOD_CK1_1 | 212 | 218 | PF00069 | 0.523 |
MOD_CK2_1 | 51 | 57 | PF00069 | 0.262 |
MOD_Cter_Amidation | 11 | 14 | PF01082 | 0.278 |
MOD_DYRK1A_RPxSP_1 | 135 | 139 | PF00069 | 0.553 |
MOD_GlcNHglycan | 142 | 145 | PF01048 | 0.700 |
MOD_GlcNHglycan | 149 | 152 | PF01048 | 0.669 |
MOD_GlcNHglycan | 44 | 48 | PF01048 | 0.409 |
MOD_GSK3_1 | 112 | 119 | PF00069 | 0.626 |
MOD_GSK3_1 | 140 | 147 | PF00069 | 0.655 |
MOD_GSK3_1 | 157 | 164 | PF00069 | 0.638 |
MOD_GSK3_1 | 20 | 27 | PF00069 | 0.430 |
MOD_GSK3_1 | 49 | 56 | PF00069 | 0.365 |
MOD_GSK3_1 | 72 | 79 | PF00069 | 0.423 |
MOD_NEK2_1 | 120 | 125 | PF00069 | 0.728 |
MOD_NEK2_1 | 72 | 77 | PF00069 | 0.451 |
MOD_NEK2_2 | 126 | 131 | PF00069 | 0.567 |
MOD_PIKK_1 | 225 | 231 | PF00454 | 0.592 |
MOD_PIKK_1 | 78 | 84 | PF00454 | 0.250 |
MOD_PIKK_1 | 93 | 99 | PF00454 | 0.470 |
MOD_PKA_1 | 209 | 215 | PF00069 | 0.530 |
MOD_PKA_2 | 115 | 121 | PF00069 | 0.769 |
MOD_PKA_2 | 134 | 140 | PF00069 | 0.419 |
MOD_PKA_2 | 147 | 153 | PF00069 | 0.680 |
MOD_PKA_2 | 209 | 215 | PF00069 | 0.601 |
MOD_PKA_2 | 72 | 78 | PF00069 | 0.461 |
MOD_PKB_1 | 114 | 122 | PF00069 | 0.761 |
MOD_Plk_4 | 60 | 66 | PF00069 | 0.417 |
MOD_ProDKin_1 | 135 | 141 | PF00069 | 0.620 |
MOD_ProDKin_1 | 163 | 169 | PF00069 | 0.550 |
MOD_ProDKin_1 | 251 | 257 | PF00069 | 0.724 |
TRG_DiLeu_BaEn_1 | 246 | 251 | PF01217 | 0.609 |
TRG_DiLeu_BaEn_3 | 238 | 244 | PF01217 | 0.521 |
TRG_ENDOCYTIC_2 | 216 | 219 | PF00928 | 0.521 |
TRG_ENDOCYTIC_2 | 67 | 70 | PF00928 | 0.393 |
TRG_ENDOCYTIC_2 | 86 | 89 | PF00928 | 0.145 |
TRG_ER_diArg_1 | 189 | 191 | PF00400 | 0.587 |
TRG_ER_diArg_1 | 208 | 211 | PF00400 | 0.400 |
TRG_Pf-PMV_PEXEL_1 | 29 | 34 | PF00026 | 0.442 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P2R9 | Leptomonas seymouri | 49% | 93% |
A0A0S4J2G2 | Bodo saltans | 42% | 100% |
A0A0S4JNL3 | Bodo saltans | 24% | 100% |
A0A1X0P9F2 | Trypanosomatidae | 44% | 100% |
A0A3Q8IH20 | Leishmania donovani | 89% | 100% |
A0A422N0I0 | Trypanosoma rangeli | 42% | 100% |
A4HNY8 | Leishmania braziliensis | 75% | 100% |
A4ICK5 | Leishmania infantum | 89% | 100% |
Q4Q1U5 | Leishmania major | 86% | 100% |
V5BQB2 | Trypanosoma cruzi | 43% | 100% |